Four Kansas virologists trace their paths into science and the host defences, macrodomains and H5N1 risks they study.
The bad news is there is a lot of this virus around and environmental contamination is very high. The good news, from the limited sequences released, is that the only real adaptive mutation is in PB2, position 631 from M to L, with very few carrying 627K. That can change tomorrow.
Answered around 58:59It started from one event in Texas in 2024 and has since infected more than 1,000 farms, about 1,100, across 19 states. The virus replicates in different tropisms, mainly in the mammary gland, and infected cows excrete a high amount of virus in the milk, up to 10 to the 9th.
Answered around 58:18The bovine udder carries both alpha-2,3 and alpha-2,6 receptors, so it suits avian-like and mammalian-like influenza viruses and the virus can replicate beautifully without adapting there. The only adaptation it needs is in the polymerase: PB2 must change at 627 or 631 to interact with the mammalian ANP32 host protein.
Answered around 1:00:20Good vaccines exist: vector-based ones developed years ago that can be sprayed as an aerosol instead of injected into muscle, and they worked beautifully in chickens. But once a chicken carries antibody against H5N1, the export trade is done, and trade is billions of dollars. Even DIVA vaccines need trade restrictions lifted, which industry resists.
Answered around 1:07:19All coronaviruses encode these macrodomains, which counter the host PARPs. When the protein is knocked out or mutated, the viruses become extremely attenuated: put into mice, the animals do not even look like they got a virus infection, as if they had received water. In culture the virus still replicates and does not lose titer.
Answered around 33:52A protein can be modified with a single ADP ribose, called mono-ADP-ribosylation, or with a chain of units, poly-ADP-ribosylation. The enzymes that add it are the PARPs, also called ADP ribosyl transferases: they take NAD, break off the nicotinamide portion, and add the remaining ADP ribose onto a protein. Humans have 17 PARPs.
Answered around 26:41PTPN22 is protein tyrosine phosphatase non-receptor type 22, expressed only in immune cells, meaning all bone marrow derived cells, so it is regarded as immune regulatory. About 5 to 15 percent of the population carries a mutation, a single nucleotide change of arginine to tryptophan in an intrinsically disordered region, that raises risk for essentially all autoimmune diseases.
Answered around 39:48Mice carrying the mutation clear LCMV clone 13, the chronic strain, which wild-type mice cannot. Clearance is definitely T cell dependent, with enhanced CD4 T cell function and antigen-specific CD8 enhancement, not against the commonly studied GP33 epitope but a different one, plus dendritic cells that appear more immunostimulatory. It is a multi-cell process.
Answered around 45:51Yes. In work published in collaboration with Tony, mice carrying the mutation had improved survival during coronavirus infection with MHV A59, a liver-tropic coronavirus. Wild-type mice in the colony show about 50 percent survival, while mice with the mutation show about 90 to 100 percent, due in part to innate immunity and natural killer cells.
Answered around 46:49In this lab's hands the virus is incredibly pathogenic: all the flies they infect are dead in nine days or something like that. That contrasts with the Drosophila RNA viruses, which persisted in lab stocks for decades because they are not very pathogenic in terms of vertical transmission. Finding it required collecting flies in the wild.
Answered around 1:18:15“It is the hardest job I've ever done.”
“In the end, the host wins, basically.”
“I like complex problems that seem to never be solved.”
“It's maybe $10 billion already in losses.”
“Virology Careers and Research.” https://traffic.libsyn.com/secure/twiv/TWiV1311.mp3. Transcript summary by WhipScribe, https://whipscribe.com/transcript-pages/virology-careers-and-research.html.